Type 2 Diabetes Mellitus Clinical Trial
— SUKALMENAOfficial title:
HOME COOKING: Health Empowerment Strategy in People With Type II Diabetes Mellitus (SUKALMENA)
NCT number | NCT04449120 |
Other study ID # | 04.0006.19 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 1, 2020 |
Est. completion date | March 30, 2021 |
Verified date | January 2021 |
Source | Basque Culinary Center Fundazioa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Currently, one of the health challenges in the field of public health is to improve the quality of life of people with metabolic diseases, using new strategies that allow to promote healthy eating habits. Within the new strategies that may encourage population improving eating habits, "HOMECOOKING" is proposed as a transforming tool for health, involving culinary skills and knowledge in nutrition. It is suggested as a new paradigm in nutritional education. This project will cover the "HOMECOOKING: cooking and eating at home", as an innovative strategy, aiming to improve the quality of the diet of people with type II diabetes mellitus through an intervention based on cooking workshops. At these sessions, participants will learn easy cooking techniques and tools, in order to acquire culinary competences and to be empowered to prepare healthy dishes. The effect of this intervention programme on the health of the participants will be evaluated through the measurement of biochemical parameters related to the disease (glycosylated haemoglobin, insulin, glucose, among others). In addition, specific compounds known as advanced glycation end products (AGEs) will be measured. The formation of these compounds is associated with the type of food consumed and the culinary techniques that are applied.
Status | Completed |
Enrollment | 58 |
Est. completion date | March 30, 2021 |
Est. primary completion date | March 15, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Patients with type 2 Diabetes Mellitus without treatment with insulin, sulfonylureas and glinides. - Overweight or obesity (BMI between 25 and 40 kg/m2). - Stable treatment with oral antidiabetics, other than sulfonylureas or glinides, at least for 3 months. Exclusion Criteria: - Treatment with insulin, sulfonylureas or glinides - Glycosylated hemoglobin (HbA1c) concentration greater than 10% - Weight loss exceeding 5 kg in the past three months - Pregnant or breastfeeding women - Serious medical condition that impedes from conducting the dietary intervention or that limits the survival to less than one year - Consumption of illegal drugs, chronic alcoholism or alcohol total consumption above 80 g/day - Participation in other clinical trial with drugs or nutritional intervention during the previous year to inclusion - Major difficulties or inconveniences in changing dietary habits and following the Mediterranean Diet (allergies, intolerances) - Difficulties for regular home cooking and/or eating out more than 2 days per week - Current diagnosis of an eating disorder, schizophrenia, other psychotic disorder or bipolar disorder - Hospitalization for any mental illness in the previous year - History of bariatric surgery or extensive bowel resection |
Country | Name | City | State |
---|---|---|---|
Spain | Basque Culinary Center | Donostia-San Sebastian | Guipuzcoa |
Lead Sponsor | Collaborator |
---|---|
Basque Culinary Center Fundazioa | University of Navarra |
Spain,
Bernardo GL, Jomori MM, Fernandes AC, Colussi CF, Condrasky MD, Proença RPDC. Nutrition and Culinary in the Kitchen Program: a randomized controlled intervention to promote cooking skills and healthy eating in university students - study protocol. Nutr J. 2017 Dec 20;16(1):83. doi: 10.1186/s12937-017-0305-y. — View Citation
Byrne C, Kurmas N, Burant CJ, Utech A, Steiber A, Julius M. Cooking Classes: A Diabetes Self-Management Support Intervention Enhancing Clinical Values. Diabetes Educ. 2017 Dec;43(6):600-607. doi: 10.1177/0145721717737741. Epub 2017 Oct 19. — View Citation
Irl B H, Evert A, Fleming A, Gaudiani LM, Guggenmos KJ, Kaufer DI, McGill JB, Verderese CA, Martinez J. Culinary Medicine: Advancing a Framework for Healthier Eating to Improve Chronic Disease Management and Prevention. Clin Ther. 2019 Oct;41(10):2184-2198. doi: 10.1016/j.clinthera.2019.08.009. Epub 2019 Sep 20. — View Citation
Polak R, Tirosh A, Livingston B, Pober D, Eubanks JE Jr, Silver JK, Minezaki K, Loten R, Phillips EM. Preventing Type 2 Diabetes with Home Cooking: Current Evidence and Future Potential. Curr Diab Rep. 2018 Sep 14;18(10):99. doi: 10.1007/s11892-018-1061-x. Review. — View Citation
Reicks M, Kocher M, Reeder J. Impact of Cooking and Home Food Preparation Interventions Among Adults: A Systematic Review (2011-2016). J Nutr Educ Behav. 2018 Feb;50(2):148-172.e1. doi: 10.1016/j.jneb.2017.08.004. Epub 2017 Sep 25. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in fasting glycosylated hemoglobin level | At baseline blood samples will be collected for determination of hemoglobin A1c. At 3 months of follow-up, the determination of this parameter will be repeated. | Baseline; three months follow-up | |
Primary | Change in fasting glucose level | At baseline blood samples will be collected for determination of fasting glucose levels. At 3 months of follow-up, the determination of this parameter will be repeated. | Baseline; three months follow-up | |
Primary | Change in fasting insulin level | At baseline blood samples will be collected for determination of fasting insulin levels. At 3 months of follow-up, the determination of this parameter will be repeated. | Baseline; three months follow-up | |
Secondary | Change in advanced glycation end products (AGEs) level | At baseline blood samples will be collected for determination of advanced glycation end products levels. At 3 months of follow-up, this determination will be repeated. | Baseline; three months follow-up | |
Secondary | Changes in hip circumference | At baseline, hip circumference will be measured with a measuring. At 3 months of follow-up , the determination of this measurement will be repeated. | Baseline; three months follow-up | |
Secondary | Changes in waist circumference | At baseline, waist circumference will be measured with a measuring. At 3 months of follow-up , the determination of this measurement will be repeated. | Baseline; three months follow-up | |
Secondary | Changes in body mass index (BMI) | BMI will be calculated as body weight (kg) divided by height (m) squared at baseline and at 3 months of follow up. | Baseline; three months follow-up | |
Secondary | Change in fat mass | At baseline and at 3 months of follow-up, fat mass will be analyzed by bioimpedance. | Baseline; three months follow-up | |
Secondary | Change in fat free mass | At baseline and at 3 months of follow-up, fat free mass will be analyzed by bioimpedance. | Baseline; three months follow-up | |
Secondary | Changes in lipid metabolism parameters | At baseline blood samples will be collected for determination of in fasting total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides levels. At 3 months of follow-up, the determination of these parameters will be repeated. | Baseline; three months follow-up | |
Secondary | Change in blood pressure | At baseline systolic blood pressure and diastolic blood pressure will be reported in mmHg.
At 3 months of follow-up, the determination of systolic and diastolic blood pressure will be repeated. |
Baseline; three months follow-up | |
Secondary | Change in plasma C-reactive protein | At baseline blood samples will be collected for determination of C-reactive protein. At 3 months of follow-up, the determination of this parameter will be repeated. | Baseline; three months follow-up | |
Secondary | Change in adherence to the Mediterranean Diet measured by Mediterranean Diet Adherence Screener | At baseline data about adherence to the Mediterranean Diet will be collected by a 14-point Mediterranean Diet Adherence Screener (MEDAS). At 1 and 3 months of follow-up these data will be also collected. | Baseline; one month; three months follow-up | |
Secondary | Change in dietary intake measured by validated Food Frequency Questionnaire (FFQ) | At baseline data about dietary intake will be collected by using a Food Frequency Questionnaire (FFQ). At 3 months of follow-up, these data will be also collected. | Baseline; three months follow-up | |
Secondary | Change in quality of life measured by Quality of Life Questionnaire | At baseline and at 3 months of follow-up, data about quality of life will be measured by Quality of Life Questionnaire. | Baseline; three months follow-up | |
Secondary | Change in physical activity level measured by the Minnesota Leisure-Time Physical Activity Questionnaire | At baseline and at 3 months of follow-up, data about physical activity level will be collected by the Minnesota Leisure-Time Physical Activity Questionnaire | Baseline; three months follow-up | |
Secondary | Change in culinary habits measured by Culinary Habits Frequency Questionnaire (CHFC) | At baseline and at 3 months of follow-up, data about culinary habits will be collected by culinary habits frequency questionnaire. | Baseline; three months follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02771093 -
An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT02545842 -
Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)
|
Phase 4 | |
Recruiting |
NCT03436212 -
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
|
N/A | |
Completed |
NCT03244800 -
A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
|
Phase 2 | |
Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
Withdrawn |
NCT02769091 -
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT06065540 -
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
|
Phase 3 | |
Recruiting |
NCT05008276 -
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
|
||
Completed |
NCT04091373 -
A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide
|
Phase 1 | |
Completed |
NCT03296800 -
Study to Evaluate Effects of Probenecid, Rifampin and Verapamil on Bexagliflozin in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT06212778 -
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
|
||
Completed |
NCT05979519 -
Fresh Carts for Mom's to Improve Food Security and Glucose Management
|
N/A | |
Recruiting |
NCT05579314 -
XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Terminated |
NCT03684642 -
Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin
|
Phase 3 | |
Completed |
NCT03248401 -
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
Phase 4 | |
Completed |
NCT03644134 -
A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns
|
N/A | |
Completed |
NCT05295160 -
Fasting-Associated Immune-metabolic Remission of Diabetes
|
N/A | |
Completed |
NCT02836873 -
Safety and Efficacy of Bexagliflozin in Type 2 Diabetes Mellitus Patients With Moderate Renal Impairment
|
Phase 3 | |
Completed |
NCT02226003 -
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
|
Phase 3 |